2024 ASCO® Annual Meeting Insights Hub
Meeting coverage & Vumedi’s exclusive highlights, all in one place.
Playback speed
10 seconds
ASCO® 2024 Summary: "Highlights in Melanoma - Neoadjuvant and Adjuvant Treatments, 1L Metastatic & Anti-PD-1 Refractory Disease"
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Zeynep Eroglu
By
2024 ASCO® Annual Meeting Insights Hub
FEATURING
Zeynep Eroglu
322 views
July 5, 2024
Login to view comments.
Click here to Login